Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Journal of Pharmaceutical Sciences|June 4, 2025
Disintegration-dissolution modeling of bilayer tablets: Predicting plasma profiles and antimicrobial efficacy under postprandial conditionsStefan Horkovics-Kovats, Jozef Federič, Martina Kinzig, et al.Nutrients|June 10, 2022
Caffeine, Paraxanthine, Theophylline, and Theobromine Content in Human MilkAleksandra Purkiewicz, Renata Pietrzak-Fiećko, Fritz Sörgel, et al.European Journal of Clinical Pharmacology|August 16, 2008
Mesalazine pharmacokinetics and NAT2 phenotypeHendrik Lück, Martina Kinzig, Alexander Jetter, et al.Journal of Pharmaceutical and Biomedical Analysis|June 15, 2021
The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMSJonas Wohlfart, Oliver Scherf-Clavel, Martina Kinzig, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 4, 2011
An LC-MS/MS procedure for the quantification of naproxen in human plasma: development, validation, comparison with other methods, and application to a pharmacokinetic studyPaul W Elsinghorst, Martina Kinzig, Michael Rodamer, et al.Journal of Pharmaceutical and Biomedical Analysis|April 25, 2024
Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometryLaura Backer, Martina Kinzig, Fritz Sörgel, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 4, 2011
Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative studyMichael Rodamer, Paul W Elsinghorst, Martina Kinzig, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 23, 2019
Quantification of adefovir and pitavastatin in human plasma and urine by LC-MS/MS: A useful tool for drug-drug interaction studiesOliver Scherf-Clavel, Martina Kinzig, Marc S Stoffel, et al.Pharmacology|January 6, 2009
Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrationsFritz Sörgel, Ursula Thyroff-Friesinger, Andrea Vetter, et al.Clinical Pharmacokinetics|March 11, 2009
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerationsCornelia B Landersdorfer, Jürgen B Bulitta, Martina Kinzig, et al.Pageof 9